Delivery Order SPE2DB22D1017-SPE2DB24FF0WU
Award Date
1/8/24
Potential Completion Date
1/9/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,337.52, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of March 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Cyclosporine 0.05% eye emulsion to the government. The $7,560.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 3, 2025, with a completion date of January 6, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion 60s, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,546.26 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 17, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm-fixed-price delivery order. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $9,057.01. The contract has an ultimate completion date of October 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is for the supply of Cyclosporine 0.05% eye emulsion by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,134.44, was awarded by the Defense Logistics Agency (DLA) on July 2, 2024, with a completion date of July 3, 2024. The contract is a Delivery Order under a Firm Fixed Price (FFP) pricing type. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, the prime...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $2,650.58 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The contract has an ultimate completion date of August 31, 2023 and was awarded on August 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for $7,424.52 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The $28,455.22 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $1,922.86, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2024. The contract has a firm fixed price and an ultimate completion date of September 25, 2024. This is a delivery order contract, and there is no set-aside designation noted. Amerisourcebergen has been awarded numerous federal contracts,...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,460.42 and an ultimate completion date of January 29, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...